Sarclisa (isatuximab-irfc) for the Treatment of Multiple Myeloma

Image 2-Sarclisa
Sarclisa is an anti-CD3 monoclonal antibody that attacks multiple myeloma cancer cells. Credit: Sanofi-Aventis.